Determining outcomes, adverse events, and predictors of success after sacral neuromodulation for lower urinary disorders in women
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Obstetrics and Gynaecology
Link
http://link.springer.com/content/pdf/10.1007/s00192-011-1512-2.pdf
Reference20 articles.
1. Steers WD, Herschorn S, Kreder KJ et al (2007) Duloxetine OAB Study Group. Duloxetine compared with placebo for treating women with symptoms of overactive bladder. BJU Int 100(2):337–45
2. Hu T, Wagner TH, Bentkover JD et al (2003) Estimated economic costs of overactive bladder in the United States. Urology 61(6):1123–1128
3. Abrams P, Freeman R, Anderstrom C, Mattiason A (1998) Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol 81:801–810
4. Tanagho EA, Schmidt RA (1988) Electrical stimulation in the clinical management of the neurogenic bladder. J Urol 140:1331–9
5. Brazzelli M, Murray A, Fraser C (2006) Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol 175(3):835–841
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Peripheral Nerve Stimulation;Topics in Pain Management;2023-02
2. Does response to percutaneous tibial nerve stimulation predict similar outcome to sacral nerve stimulation?;Neurourology and Urodynamics;2022-04-28
3. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects;Expert Review of Medical Devices;2022-02-01
4. Development of a prediction model in female pure or predominant urge urinary incontinence: a retrospective cohort study;Therapeutic Advances in Urology;2022-01
5. Résultats fonctionnels et satisfaction chez 44 patients post implantation de neurostimulateur sacré type NS3 pour une hyperactivité vésicale réfractaire, d’origine idiopathique, suivi à 43 mois, série monocentrique;Progrès en Urologie;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3